Nyxoah S.A. (NYXH)

NASDAQ: NYXH · IEX Real-Time Price · USD
9.09
-0.63 (-6.48%)
At close: Apr 12, 2024, 3:59 PM
8.94
-0.15 (-1.65%)
After-hours: Apr 12, 2024, 4:59 PM EDT
-6.48%
Market Cap 258.24M
Revenue (ttm) 4.83M
Net Income (ttm) -48.01M
Shares Out 28.66M
EPS (ttm) -1.65
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 35,556
Open 10.06
Previous Close 9.72
Day's Range 8.60 - 10.25
52-Week Range 4.00 - 20.00
Beta 0.48
Analysts Strong Buy
Price Target 18.40 (+102.42%)
Earnings Date May 14, 2024

About NYXH

Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company's lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium. [Read more]

Sector Healthcare
IPO Date Jul 2, 2021
Employees 137
Stock Exchange NASDAQ
Ticker Symbol NYXH
Full Company Profile

Financial Performance

In 2023, Nyxoah's revenue was 4.35 million, an increase of 40.99% compared to the previous year's 3.08 million. Losses were -43.21 million, 38.4% more than in 2022.

Financial numbers in EUR Financial Statements

Analyst Forecast

According to 6 analysts, the average rating for NYXH stock is "Strong Buy." The 12-month stock price forecast is $18.4, which is an increase of 102.42% from the latest price.

Price Target
$18.4
(102.42% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

Nyxoah Appoints Dr. Maurits S. Boon, MD as Chief Medical Officer

Nyxoah Appoints Dr. Maurits S. Boon, MD as Chief Medical Officer Mont-Saint-Guibert, Belgium – April 11, 2024, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Co...

1 day ago - GlobeNewsWire

Nyxoah Advances Patient Access Strategy through Partnership with the American Association of Otolaryngology – Head & Neck Surgery Foundation

Nyxoah Advances Patient Access Strategy through Partnership with the American Association of Otolaryngology – Head & Neck Surgery Foundation First medical device company to become a corporate champion...

19 days ago - GlobeNewsWire

Nyxoah Announces DREAM U.S. Pivotal Study Meets Primary Endpoints

Nyxoah Announces DREAM U.S. Pivotal Study Meets Primary Endpoints Reports an Apnea-Hypopnea Index (AHI) responder rate of 63.5% on an intent to treat (ITT) basis (p=0.002) Reports an Oxygen Desaturati...

24 days ago - GlobeNewsWire

Nyxoah Reports Fourth Quarter and Financial Year 2023 Financial and Operating Results

Nyxoah Reports Fourth Quarter and Financial Year 2023 Financial and Operating Results Expect to report DREAM U.S. pivotal study efficacy and safety data by early April Achieved record quarterly sales ...

5 weeks ago - GlobeNewsWire

Nyxoah to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference

Nyxoah to Participate in the Oppenheimer 34 th Annual Healthcare MedTech & Services Conference

6 weeks ago - GlobeNewsWire

Nyxoah to Release Fourth Quarter and Financial Year 2023 Financial Results on March 5, 2024

Nyxoah to Release Fourth Quarter and Financial Year 2023 Financial Results on March 5, 2024 Mont-Saint-Guibert, Belgium – February 15, 2024, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasd...

2 months ago - GlobeNewsWire

Nyxoah Announces 2024 Strategic Priorities

Nyxoah Announces 2024 Strategic Priorities Mont-Saint-Guibert, Belgium – January 17, 2024, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical t...

3 months ago - GlobeNewsWire

Nyxoah Announces Preliminary Results for the Fourth Quarter and Full Year 2023

Nyxoah Announces Preliminary Results for the Fourth Quarter and Full Year 2023 Mont-Saint-Guibert, Belgium – January 9, 2024, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyx...

3 months ago - GlobeNewsWire

Nyxoah Announces Real World Case Series Demonstrating Positive Results in Treating CCC Patients with Genio®

Nyxoah Announces Real World Case Series Demonstrating Positive Results in Treating CCC Patients with Genio® Data presented at the DGSM Conference in Berlin by Dr. Christian Plettenberg on December 8, ...

4 months ago - GlobeNewsWire

Publication Relating to a Transparency Notification

REGULATED INFORMATION Publication Relating to a Transparency Notification Mont-Saint-Guibert (Belgium), December 8, 2023, 10.30pm CET / 4.30pm ET – In accordance with article 14 of the Act of 2 May 20...

4 months ago - GlobeNewsWire

Nyxoah Strengthens its Executive Leadership Team

Nyxoah Strengthens its Executive Leadership Team Francis Kim appointed as Chief Regulatory and Quality Officer

4 months ago - GlobeNewsWire

Nyxoah to Participate in the Piper Sandler 35th Annual Healthcare Conference

Nyxoah to Participate in the Piper Sandler 35 th Annual Healthcare Conference

5 months ago - GlobeNewsWire

Nyxoah Reports Third Quarter 2023 Financial and Operating Results

Nyxoah Reports Third Quarter 2023 Financial and Operating Results Partners with ResMed Germany to increase OSA awareness and therapy penetration

5 months ago - GlobeNewsWire

Nyxoah to Participate in the Jefferies London Healthcare Conference

Nyxoah to Participate in the Jefferies London Healthcare Conference Mont-Saint-Guibert, Belgium – November 7, 2023, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or th...

5 months ago - GlobeNewsWire

Nyxoah to Release Third Quarter 2023 Financial Results on November 8, 2023

Nyxoah to Release Third Quarter 2023 Financial Results on November 8, 2023 Mont-Saint-Guibert, Belgium – October 26, 2023, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah...

6 months ago - GlobeNewsWire

Nyxoah Announces Partnership with ResMed in Germany

Nyxoah Announces Partnership with ResMed in Germany C reates a continuum of care in the German obstructive sleep apnea market

7 months ago - GlobeNewsWire

Nyxoah to Participate in the Cantor Fitzgerald Global Healthcare Conference

Nyxoah to Participate in the Cantor Fit z gerald Global Healthcare Conference

7 months ago - GlobeNewsWire

Nyxoah to Participate in Upcoming Investor Conferences

Nyxoah to Participate in Upcoming Investor Conferences Mont-Saint-Guibert, Belgium – September 5 , 2023, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”...

7 months ago - GlobeNewsWire

Nyxoah Reports Second Quarter and First Half 2023 Financial and Operating Results

REGULATED INFORMATION Nyxoah Reports Second Q uarter and First Half 2 02 3 Financial and Operating Results Mont-Saint-Guibert, Belgium – August 8 , 2023 10 : 0 5 pm CET / 4 : 0 5pm ET – Nyxoah SA ( Eu...

8 months ago - GlobeNewsWire

Nyxoah to Release Second Quarter 2023 Financial Results on August 8, 2023

Nyxoah to Release Second Quarter 2023 Financial Results on August 8 , 202 3

9 months ago - GlobeNewsWire

Nyxoah to Participate in the 43rd Canaccord Genuity Growth Conference

Nyxoah to Participate in the 43rd Canaccord Genuity Growth Conference

9 months ago - GlobeNewsWire

Nyxoah Reports First Quarter 2023 Financial and Operating Results

REGULATED INFORMATION   Nyxoah Reports First Quarter 2023 Financial and Operating Results Mont-Saint-Guibert, Belgium – May 16, 2023 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH...

11 months ago - GlobeNewsWire

Invitation to Attend the Annual Shareholders' Meeting of the Company to be Held on June 14, 2023

REGULATED INFORMATION May 12, 2023, 7:00am CET / 1:00am ET NYXOAH SA (Euronext Brussels: NYXH)Rue Edouard Belin 12, 1435 Mont-Saint-Guibert, Belgium(hereinafter the “Company”) Invitation to Attend the...

1 year ago - GlobeNewsWire

Nyxoah Appoints Christoph Eigenmann as Chief Commercial Officer

Nyxoah Appoints Christoph Eig enmann as Chief Commercial Officer

1 year ago - GlobeNewsWire

Nyxoah to Release First Quarter 2023 Financial Results on May 16, 2023

Nyxoah to Release F irst Quarter 2023 Financial Results on Ma y 16 , 202 3

1 year ago - GlobeNewsWire